Nu Skin Enterprises Price Target Raised to $110.00 at Deutsche Bank (NUS)
Deutsche Bank increased their price objective on shares of Nu Skin Enterprises (NYSE:NUS) from $100.00 to $110.00 in a research note issued on Tuesday, AnalystRatings.Net reports. The firm currently has a “buy” rating on the stock. Deutsche Bank’s price objective would suggest a potential upside of 11.57% from the company’s current price.
Shares of Nu Skin Enterprises (NYSE:NUS) traded down 3.02% during mid-day trading on Tuesday, hitting $95.61. 1,137,654 shares of the company’s stock traded hands. Nu Skin Enterprises has a 52 week low of $32.36 and a 52 week high of $100.00. The stock has a 50-day moving average of $91.61 and a 200-day moving average of $70.26. The company has a market cap of $5.609 billion and a price-to-earnings ratio of 24.87.
Nu Skin Enterprises (NYSE:NUS) last released its earnings data on Thursday, August 1st. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.96 by $0.26. The company had revenue of $682.90 million for the quarter, compared to the consensus estimate of $579.10 million. During the same quarter in the previous year, the company posted $0.94 earnings per share. The company’s revenue for the quarter was up 15.1% on a year-over-year basis.
NUS has been the subject of a number of other recent research reports. Analysts at Zacks downgraded shares of Nu Skin Enterprises from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, October 2nd. They now have a $101.20 price target on the stock. Separately, analysts at Sidoti downgraded shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating in a research note to investors on Friday, September 27th. Finally, analysts at DA Davidson downgraded shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating in a research note to investors on Thursday, September 12th. They noted that the move was a valuation call. Six analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Nu Skin Enterprises currently has a consensus rating of “Hold” and an average price target of $90.70.
Nu Skin Enterprises, Inc is a global direct selling company with operations in 53 markets worldwide. The Company develops and distributes anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands, respectively.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.